@inbook{7ee4756e25504f8284c0afcc014adddd,
title = "Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection",
abstract = "Hendra virus (HeV) and Nipah virus (NiV) are highly pathogenic paramyxoviruses, which have emerged in recent decades and cause sporadic outbreaks of respiratory and encephalitic disease in Australia and Southeast Asia, respectively. Over two billion people currently live in regions potentially at risk due to the wide range of the Pteropus fruit bat reservoir, yet there are no approved vaccines or therapeutics to protect against or treat henipavirus disease. In recent years, significant progress has been made toward developing various experimental vaccine platforms and therapeutics. Here, we describe these advances for both human and livestock vaccine candidates and discuss the numerous preclinical studies and the few that have progressed to human phase 1 clinical trial and the one approved veterinary vaccine.",
keywords = "Hendra, Henipavirus, Nipah, Therapeutics, Vaccine, Virus",
author = "Satterfield, {Benjamin A.} and Mire, {Chad E.} and Geisbert, {Thomas W.}",
note = "Publisher Copyright: {\textcopyright} 2023, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2023",
month = aug,
day = "23",
doi = "10.1007/978-1-0716-3283-3_1",
language = "English (US)",
volume = "2682",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "1--22",
booktitle = "Methods in Molecular Biology",
}